“School of Nano-Sciences”
Back to Papers HomeBack to Papers of School of Nano-Sciences
| Paper IPM / Nano-Sciences / 18349 |
|
||||||||||||
| Abstract: | |||||||||||||
|
Numerous attempts have been devoted to designing anti-angiogenic agents as a strategy to slow tumor growth and progression. Clinical applications of conventional anti-angiogenic agents face some challenges, e.g., off-target effects for TKIs and also low solid tumor penetration for mAbs. Furthermore, although anti-angiogenic therapy provides a normalization window for better chemo-RT response, in long-term treatments, tumor hypoxia as a result of total removal of VEGF-A by mAbs from the TME or complete blockade of TK receptors induces over-activation of compensatory angiogenic pathways, causing escape. Herein, we investigate the efficacy of si-DOX-DC-EVs to reduce glioma angiogenesis and invasiveness.
Download TeX format |
|||||||||||||
| back to top | |||||||||||||
